PeerVoice Endocrinology & Metabolic Disorders Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 22m. Bisher sind 107 Folge(n) erschienen. Dieser Podcast erscheint alle 3 Wochen.

Gesamtlänge aller Episoden: 1 day 21 hours 21 minutes

subscribe
share






PARP Inhibitors for Ovarian Cancer: Making the Right Choices at the Right Times


PARP Inhibitors for Ovarian Cancer: Making the Right Choices at the Right Times


share








 October 31, 2019  9m
 
 

Getting at the Heart of Comprehensive Disease Control in Type 2 Diabetes: What’s New?


Visit https://www.peervoice.com/QZR860 to view the entire programme with slides.


share








 October 24, 2019  1h17m
 
 

A Closer Look at Safety of Glucose-Lowering Therapy


A Closer Look at Safety of Glucose-Lowering Therapy


share








 February 28, 2019  18m
 
 

Improving Outcomes in Type 2 Diabetes: Focus on Cardiovascular and Renal Safety


Improving Outcomes in Type 2 Diabetes: Focus on Cardiovascular and Renal Safety


share








 November 7, 2018  1h13m
 
 

Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa


Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa


share








 October 18, 2018  1h10m
 
 

Considering the Possibility of Psoriatic Arthritis in Patients With Psoriasis


Considering the Possibility of Psoriatic Arthritis in Patients With Psoriasis


share








 April 26, 2018  16m
 
 

Cardiovascular and Renal Safety in Type 2 Diabetes: What Clinicians Need to Know


Cardiovascular and Renal Safety in Type 2 Diabetes: What Clinicians Need to Know


share








 April 21, 2018  20m
 
 

Modern Management of Patients With Rheumatic Diseases: What Pharmacists Need to Know About Biologic Therapies


Go online to www.peervoice.com/XQA860 to view the entire programme with slides.


share








 March 15, 2018  16m
 
 

SGLT2 Inhibitors: From A1C to Cardiac and Renal Outcomes


SGLT2 Inhibitors: From A1C to Cardiac and Renal Outcomes


share








 January 17, 2018  17m
 
 
share








 January 4, 2018  21m